NUS Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

374.20M

-13.01%

0.300

+76.47%

382.70M

-14.11%

0.300

-21.05%

Estimates Revision

The market is revising No Change the revenue expectations for Nu Skin Enterprises, Inc. (NUS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -10.41%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-10.41%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for NU Skin Enterprises Inc (NUS.N) is 7.98, compared to its 5-year average forward P/E of 12.29. For a more detailed relative valuation and DCF analysis to assess NU Skin Enterprises Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

12.29

Current PE

7.98

Overvalued PE

16.81

Undervalued PE

7.77

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

6.19

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

9.01

Undervalued EV/EBITDA

3.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.65

Current PS

0.00

Overvalued PS

0.99

Undervalued PS

0.31

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NUS News & Events

Events Timeline

No data

News

2.0

12-12NASDAQ.COM

e.l.f. Beauty Drops 38% in 2025: Strategies for Investing in 2026

2.0

09-23NASDAQ.COM

Nu Skin (NUS) Shows Promise: Will Its 6.2% Surge Lead to Further Gains?

8.0

09-22NASDAQ.COM

Significant Options Activity on Monday: BBY, NUS, RUN

People Also Watch

Frequently Asked Questions

What is NU Skin Enterprises Inc (NUS) stock price today?

The current price of NUS is 10.5 USD — it has decreased -1.04 % in the last trading day.

What is NU Skin Enterprises Inc (NUS)'s business?

Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.

What is the price predicton of NUS Stock?

Wall Street analysts forecast NUS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NU Skin Enterprises Inc (NUS)'s revenue for the last quarter?

NU Skin Enterprises Inc revenue for the last quarter amounts to 364.21M USD, decreased -15.33 % YoY.

What is NU Skin Enterprises Inc (NUS)'s earnings per share (EPS) for the last quarter?

NU Skin Enterprises Inc. EPS for the last quarter amounts to 0.34 USD, increased 100.00 % YoY.

What changes have occurred in the market's expectations for NU Skin Enterprises Inc (NUS)'s fundamentals?

How many employees does NU Skin Enterprises Inc (NUS). have?

NU Skin Enterprises Inc (NUS) has 3100 emplpoyees as of December 16 2025.

What is NU Skin Enterprises Inc (NUS) market cap?

Today NUS has the market capitalization of 511.88M USD.